Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TNF-a Antagonists Attenuate the Systemic Inflammatory Response in Post-cardiac Arrest Syndrome: a Multi Centre, Double-blind, Randomised Controlled Clinical Study

NCT07176754 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT07176754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07176754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TNF-a Antagonists Attenuate the Systemic Inflammatory Response in Post-cardiac Arrest Syndrome: a Multi Centre, Double-blind, Randomised Controlled Clinical Study
Lead sponsor
Peking University Third Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 1, 2025
Completion date
October 31, 2028
Enrollment
208 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrest (ca), post cardiac arrest syndrome